The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma
Oncotarget | July 7, 2021 | Volume: 12 | Issue: 15 | Pages: 1490-1498
10.18632/oncotarget.28025
| PMID 34316329